Clinical Trials Logo
  1. Home
  2. Anemia
  3. NCT05833178
  4. Details
NCT05833178 Clinical Trial

The Effect of Blood Tests Performed Within the Routine Protocol in the Surgical Intensive Care Unit on Hemoglobin Levels

Anemia Clinical Trial

Official title:
The Effect of Blood Tests Performed Within the Routine Protocol in the Surgical Intensive Care Unit on Hemoglobin Levels

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT05833178
Other study ID # SUKAEK-2023 5/22
Secondary ID
Status Completed
Phase
First received
Last updated
Start date April 1, 2023
Est. completion date May 31, 2023

Study information
Verified date June 2023
Source Samsun University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Examination of blood samples is inevitable in intensive care units. Routine blood samples can be an important cause for anemia. In this study, we aimed to examine how our blood collection routine affects hemoglobin values.

Description:

Blood tests for follow-up and treatment are widely used in intensive care units (ICU). Although its etiology is very diverse, phlebotomy performed due to frequent laboratory tests is among the preventable causes of anemia. In this observational study, blood tests performed on patients treated in intensive care units followed up in our clinic between 01.April.2023 - 31.May.2023 (2 months) will be examined. Patients' age, presence of additional disease, indication for admission to the unit, Acute Physiology and Chronic Health Assessment II (APACHE II), Sequential Organ Failure Assessment (SOFA) and Glasgow coma scale (GCS), hemoglobin values will be recorded. The daily blood test will record the amount of blood drawn for analysis (in milliliters), where it was taken from (peripheral, central venous or arterial catheter), and the amount of excess blood. Statistical analysis will be performed in terms of patient characteristics, routine blood volumes and development of anemia.

Recruitment information / eligibility
Status Completed
Enrollment 59
Est. completion date May 31, 2023
Est. primary completion date May 30, 2023
Accepts healthy volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Patients followed in the intensive care unit for more than 48 hours, =18-year-old Exclusion Criteria: - Patients not followed up by our clinic,=18-year-old

Study Design

Related Conditions & MeSH terms

Intervention

Behavioral:
• Drawn Blood Volume
Hemoglobine Changes

Locations
Country Name City State
Turkey Dilan Akyurt Samsun

Sponsors (1)
Lead Sponsor Collaborator
Samsun University

Country where clinical trial is conducted

Turkey, 

References & Publications (2)

Helmer P, Hottenrott S, Steinisch A, Roder D, Schubert J, Steigerwald U, Choorapoikayil S, Meybohm P. Avoidable Blood Loss in Critical Care and Patient Blood Management: Scoping Review of Diagnostic Blood Loss. J Clin Med. 2022 Jan 10;11(2):320. doi: 10.3390/jcm11020320. — View Citation

Siegal DM, Manning N, Jackson Chornenki NL, Hillis CM, Heddle NM. Devices to Reduce the Volume of Blood Taken for Laboratory Testing in ICU Patients: A Systematic Review. J Intensive Care Med. 2020 Oct;35(10):1074-1079. doi: 10.1177/0885066618810374. Epub 2018 Nov 27. — View Citation

Outcome
Type Measure Description Time frame Safety issue
Primary Evaluation of blood volume drawn for daily routine in intensive care Daily routine blood test and blood volume determination in intensive care patients 2 months
Secondary Anemia Evaluation of how daily routine blood drawn affects patients' hemoglobin values in intensive care patients 2 months
See also
  Status Clinical Trial Phase
Terminated NCT00801931 - Double Cord Blood Transplant for Patients With Malignant and Non-malignant Disorders Phase 1/Phase 2
Completed NCT02948283 - Metformin Hydrochloride and Ritonavir in Treating Patients With Relapsed or Refractory Multiple Myeloma or Chronic Lymphocytic Leukemia Phase 1
Completed NCT03341338 - Genes-in-Action - Hepcidin Regulation of Iron Supplementation
Completed NCT00060398 - Epoetin Alfa With or Without Dexamethasone in Treating Fatigue and Anemia in Patients With Hormone-Refractory Prostate Cancer Phase 3
Recruiting NCT05384691 - Efficacy of Luspatercept in ESA-naive LR-MDS Patients With or Without Ring Sideroblasts Who do Not Require Transfusions Phase 2
Not yet recruiting NCT06309641 - Methemoglobinemia Following Intravenous Iron Treatment
Completed NCT02912533 - A Long-term Study of JR-131 in Renal Anemia Patients With Chronic Kidney Disease (CKD) Phase 3
Completed NCT02930850 - Spot-Check Noninvasive Hemoglobin (SpHb) Clinical Validation N/A
Completed NCT02912494 - A Phase III Study of JR-131 in Renal Anemia Patients With Chronic Kidney Disease (CKD) Phase 3
Completed NCT03822884 - Pharmacokinetic/Pharmacodynamic Study of 3 Subcutaneous Single Dose Epoetin Alfa Formulations in Healthy Volunteers Phase 1
Completed NCT02888171 - Impact of Ferric Citrate vs Ferrous Sulfate on Iron Parameters and Hemoglobin in Individuals With CKD and Iron Deficiency N/A
Completed NCT02384122 - Efficacy of Octreotide on Blood and Iron Requirements in Patients With Anemia Due to Angiodysplasias Phase 3
Completed NCT02603250 - Evaluation of Hemoglobin Measurement Tools for Child Anemia Screening in Rwanda N/A
Completed NCT02176759 - Iron Absorption From Rice Fortified With Ferric Pyrophosphate N/A
Completed NCT02310113 - Transfusion and Skeletal Muscle Tissue Oxygenation N/A
Completed NCT01922479 - Pilot Study of Ferric Carboxymaltose to Treat Iron Deficiency in Asians With Heart Failure Phase 4
Withdrawn NCT01934842 - A Study to Compare Analyte Levels in Blood Collected Using an Investigational Collection Device With a Commercial Predicate N/A
Completed NCT01693029 - Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa Phase 3
Completed NCT01458028 - Age and Gender Effects on the Pharmacokinetics of BAY85-3934 Phase 1
Terminated NCT01535781 - Study of the Effect of Tranexamic Acid Administered to Patients With Hip Fractures. Can Blood Loss be Reduced? N/A

External Links